F. Louis

发表论文 6 篇 · 总被引 27 次 · h-index 1

代表论文

• MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study. (2024 · The Lancet Oncology · 被引 32)
• MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study. (2026 · The Lancet Oncology · 被引 4)
• 217RO Neoadjuvant trastuzumab, pertuzumab and tucatinib without chemotherapy in HER2+ early breast cancer: The TRAIN-4 study (2026 · ESMO Open · 被引 1)
• Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study. (2026 · European Journal of Cancer)
• Image-guided adaption of systemic therapy in breast cancer patients (2025 · European Radiology)
• Abstract RF1-03: Three-year event-free survival (EFS) of the multicenter phase II TRAIN-3 study evaluating image-guided optimization of neoadjuvant chemotherapy duration in stage II and III HER2-positive breast cancer (BOOG 2018-01) (2025 · Clinical Cancer Research)